Vote Scores

Home / Companies / AnaptysBio, Inc.

Company · votes reported on Form N-PXANAB · SEC company no. 1370053

AnaptysBio, Inc.

How funds and institutional managers reported voting their shares, year to 30 June 2025

Filers reporting
255year to 30 June 2025
Against management on pay
73.8%177 of 240 reporting filers
Same, by reported shares
21.4%shares reported on Form N-PX
Meetings on file
2across 2 seasons
24.4% for70.8% against4.8% other73.8% against management250 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

255 Form N-PX filers reported votes at AnaptysBio, Inc. for the year to 30 June 2025, across one meeting.

On the advisory vote on executive pay, 177 of the 240 filers that reported a position voted against management (73.8%), 65.6 percentage points above the median company on this site (8.1%). By reported shares the figure is 21.4% (median 4.0%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Among the largest fund families, 5 voted with management on pay and 35 voted against: DWS, Fidelity, Dimensional, American Century, Principal, Victory Capital, Nuveen and TIAA and Franklin Templeton and others.

Meetings

Meeting dateSeasonFilers reportingItemsAgainst management on pay
17 Jun 2025year to 30 June 2025253573.8%
12 Jun 2024year to 30 June 2024227453.7%

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 2025AnaptysBio, Inc.Median company
Reporting filers voting against management73.8%8.1%
Reported shares voted against management21.4%4.0%

Among filers reporting on Form N-PX. The median is over 3,794 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 17 Jun 2025: say-on-pay and each shareholder proposal that could be told apart.

FamilySay-on-pay
VanguardFor
BlackRock and iSharesAgainst *
FidelityAgainst *
DimensionalAgainst *
State Street and SPDRFor
American CenturyAgainst *
Franklin TempletonAgainst *
InvescoAgainst *
EquitableAgainst *
Charles SchwabAgainst *
Nuveen and TIAAAgainst *
ProShares and ProFundsAgainst *
John Hancock and ManulifeAgainst *
Morgan Stanley, Eaton Vance and CalvertAgainst *
J.P. MorganAgainst *
Goldman SachsAgainst *
PGIM and PrudentialAgainst *
Jackson National fundsAgainst *
Northern Trust and FlexSharesFor
SEIAgainst *
T. Rowe PriceAgainst *
Lincoln FinancialFor
VoyaAgainst *
First TrustAgainst *
NationwideAgainst *
Victory CapitalAgainst *
Brighthouse FundsAgainst *
Guggenheim and RydexAgainst *
Columbia ThreadneedleAgainst *
BNY MellonFor
PrincipalAgainst *
Pacific Life fundsAgainst *
Global XAgainst *
Federated HermesAgainst *
AllianceBernsteinAgainst *
DWSAgainst *
MassMutualAgainst *
Macquarie and Delaware FundsAgainst *
Neuberger BermanAgainst *
Natixis and Loomis SaylesAgainst *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

SeasonFilers reportingAgainst management on pay, filersBy reported sharesSay-on-pay split
year to 30 June 202422853.7%12.9%
year to 30 June 202525573.8%21.4%

Category mix

Share of the vote records reported for this company, by the category filers chose.

CategoryVote recordsShare
SECTION 14A SAY-ON-PAY VOTES1,03041.2%
DIRECTOR ELECTIONS87935.2%
COMPENSATION29611.8%
AUDIT-RELATED29311.7%

Questions

How did large funds vote at AnaptysBio, Inc.?

For the year to 30 June 2025, 240 Form N-PX filers reported a say-on-pay vote at AnaptysBio, Inc.; 177 voted against management (73.8%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at AnaptysBio, Inc.?

No proposal from security holders was reported by enough filers to be shown for the year to 30 June 2025.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which AnaptysBio, Inc. reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 30 Sep 2026; the median compares 3,794 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list AnaptysBio, Inc., grouped by company. The name is the most common spelling among filers; the ticker and SEC company number come from the SEC company tickers file, matched on the exact name. Not verified by the SEC. Filings read through 30 Sep 2026; page built 1 Oct 2026.